Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-019282
Filing Date
2019-04-11
Accepted
2019-04-11 16:05:53
Documents
1
Period of Report
2019-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv518740_3.html 3  
1 OWNERSHIP DOCUMENT tv518740_3.xml 3 5117
  Complete submission text file 0001144204-19-019282.txt   6849
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ABEONA THERAPEUTICS INC. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address
Silverstein Christine Berni (Reporting) CIK: 0001772546 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 19743834